EN | TR
E-ISSN: 3061-9947
Development of Acute Myelogenous Leukemia in an Allogeneic Hematopoietic Stem Cell Transplantated Patient with Fanconi Anemia
PDF
Cite
Share
Request
Case report
VOLUME: 50 ISSUE: 3
P: 266-268
2017

Development of Acute Myelogenous Leukemia in an Allogeneic Hematopoietic Stem Cell Transplantated Patient with Fanconi Anemia

Acta Haematol Oncol Turc 2017;50(3):266-268
DOI: 10.5505/aot.2017.83997
Alparslan Merdin
Jale Yıldız
Mehmet Sinan Dal
Merih Kızıl Çakar
Ali Hakan Kaya
Emre Tekgündüz
Aykut Onursever
Fevzi Altuntaş
1. Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey
2. Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Department of Pathology, Ankara, Turkey
3.
No information available.
No information available
Received Date: 2017-05-10T11:39:55
Accepted Date: 2017-12-19T15:51:13
PDF
Cite
Share
Request

Abstract

Fanconi Anemia (FA) is an inherited form of aplastic anemia. Patients have an increased tendency to develop solid cancers and leukemias. We describe a 40-year-old woman who was diagnosed with acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation due to FA related bone marrow failure. FA patients should be under close follow-up in terms of leukemia development, especially if they have AML-related abnormal chromosomes.